Altimmune (ALT) Accumulated Depreciation & Amortization (2016 - 2024)
Historic Accumulated Depreciation & Amortization for Altimmune (ALT) over the last 15 years, with Q4 2024 value amounting to $2.2 million.
- Altimmune's Accumulated Depreciation & Amortization rose 1205.06% to $2.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.2 million, marking a year-over-year increase of 1205.06%. This contributed to the annual value of $2.2 million for FY2024, which is 1205.06% up from last year.
- According to the latest figures from Q4 2024, Altimmune's Accumulated Depreciation & Amortization is $2.2 million, which was up 1205.06% from $2.0 million recorded in Q4 2023.
- Altimmune's 5-year Accumulated Depreciation & Amortization high stood at $2.2 million for Q4 2024, and its period low was $1.1 million during Q1 2022.
- For the 5-year period, Altimmune's Accumulated Depreciation & Amortization averaged around $1.8 million, with its median value being $1.8 million (2021).
- As far as peak fluctuations go, Altimmune's Accumulated Depreciation & Amortization crashed by 3608.36% in 2022, and later surged by 3184.25% in 2023.
- Quarter analysis of 5 years shows Altimmune's Accumulated Depreciation & Amortization stood at $1.6 million in 2020, then grew by 28.03% to $2.0 million in 2021, then dropped by 26.82% to $1.5 million in 2022, then skyrocketed by 31.84% to $2.0 million in 2023, then rose by 12.05% to $2.2 million in 2024.
- Its last three reported values are $2.2 million in Q4 2024, $2.0 million for Q4 2023, and $1.5 million during Q4 2022.